Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000204318 | SCV000260510 | pathogenic | Legius syndrome | 2023-02-09 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Met266Valfs*4) in the SPRED1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 179 amino acid(s) of the SPRED1 protein. This premature translational stop signal has been observed in individuals with cafe au lait macules (PMID: 17704776; Invitae). ClinVar contains an entry for this variant (Variation ID: 220172). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects SPRED1 function (PMID: 17704776, 22751498). For these reasons, this variant has been classified as Pathogenic. |
Center for Human Genetics, |
RCV000204318 | SCV000782325 | pathogenic | Legius syndrome | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813427 | SCV002060442 | pathogenic | Noonan syndrome and Noonan-related syndrome | 2020-02-01 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV000204318 | SCV002581091 | likely pathogenic | Legius syndrome | 2022-07-27 | criteria provided, single submitter | clinical testing |